Home › Funds › Defilade Capital Management, L.P. › INSM

Defilade Capital Management, L.P. position in INSM

INSMED INC · Health Care

Defilade Capital Management, L.P. reported holding 281,838 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$30.0M, representing 4.02% of its reported portfolio and ranking #7 among its reported holdings. Defilade Capital Management, L.P. has disclosed INSM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)281.84K sh
Reported value held$30.05M
Portfolio Weight4.02%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s INSM position evolved

Defilade Capital Management, L.P. first disclosed a stake in INSM in Q4 2025 at 50,000 shares (US$8.7M). The position peaked in Q1 2026 at 194,909 shares, worth US$31.9M. Across 3 filings, Defilade Capital Management, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 281,838 shares valued at US$30.0M — an increase of 86,929 shares quarter over quarter.. Notable position changes include a 290% increase in Q1 2026 (shares fell 38% over the following quarter), a 45% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 50.00K $8.70M New
Q1 2026 194.91K $31.87M Add
Q2 2026 281.84K $30.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Defilade Capital Management, L.P. held INSM?

Defilade Capital Management, L.P. has disclosed INSM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Defilade Capital Management, L.P.'s current position in INSM?

As of Q2 2026, Defilade Capital Management, L.P. holds 281.84K shares of INSM (INSMED INC), valued at $30.05M, representing 4.02% of its reported portfolio and ranking #7.

Has Defilade Capital Management, L.P. been buying or selling INSM?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. increased its position in INSM. The position peaked in Q1 2026 at 194.91K shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.